Sotera Health ROE 2019-2024 | SHC
Current and historical return on equity (ROE) values for Sotera Health (SHC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Sotera Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-12-31 | $0.04B | $0.41B | 10.19% |
| 2024-09-30 | $0.07B | $0.47B | 15.86% |
| 2024-06-30 | $0.04B | $0.42B | 9.32% |
| 2024-03-31 | $0.05B | $0.43B | 12.95% |
| 2023-12-31 | $0.05B | $0.44B | 12.75% |
| 2023-09-30 | $-0.31B | $0.38B | -81.54% |
| 2023-06-30 | $-0.27B | $0.42B | -61.75% |
| 2023-03-31 | $-0.26B | $0.36B | -53.63% |
| 2022-12-31 | $-0.23B | $0.35B | -41.88% |
| 2022-09-30 | $0.12B | $0.61B | 19.75% |
| 2022-06-30 | $0.12B | $0.64B | 20.75% |
| 2022-03-31 | $0.14B | $0.64B | 24.07% |
| 2021-12-31 | $0.12B | $0.59B | 22.28% |
| 2021-09-30 | $0.04B | $0.53B | 7.51% |
| 2021-06-30 | $0.01B | $0.52B | 2.77% |
| 2021-03-31 | $-0.03B | $0.47B | -11.29% |
| 2020-12-31 | $-0.04B | $0.46B | -34.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.264B | $1.100B |
| Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.654B | 26.76 |
| Elevance Health (ELV) | United States | $95.024B | 12.26 |
| CVS Health (CVS) | United States | $84.108B | 12.31 |
| Cencora (COR) | United States | $56.754B | 20.60 |
| Natera (NTRA) | United States | $20.404B | 0.00 |
| DiDi Global (DIDIY) | China | $19.733B | 29.00 |
| BioMerieux (BMXMF) | France | $15.507B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.474B | 0.00 |
| ICON (ICLR) | Ireland | $12.230B | 11.37 |
| Solventum (SOLV) | United States | $11.439B | 10.66 |
| CochLear (CHEOY) | Australia | $11.362B | 0.00 |
| Revvity (RVTY) | United States | $11.225B | 18.95 |
| Doximity (DOCS) | United States | $10.619B | 55.22 |
| Viatris (VTRS) | United States | $10.051B | 3.18 |
| Medpace Holdings (MEDP) | United States | $8.864B | 23.54 |
| Avantor (AVTR) | United States | $8.852B | 12.86 |
| Sonic Healthcare (SKHHY) | Australia | $8.023B | 0.00 |
| HealthEquity (HQY) | United States | $7.414B | 36.48 |
| Charles River Laboratories (CRL) | United States | $5.826B | 11.49 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.08 |
| Alignment Healthcare (ALHC) | United States | $3.503B | 0.00 |
| Organon (OGN) | United States | $3.361B | 3.39 |
| BrightSpring Health Services (BTSG) | United States | $3.069B | 31.87 |
| Surgery Partners (SGRY) | United States | $2.814B | 32.28 |
| Concentras Parent (CON) | United States | $2.788B | 14.50 |
| Progyny (PGNY) | United States | $1.957B | 43.09 |
| GeneDx Holdings (WGS) | United States | $1.876B | 73.46 |
| Premier (PINC) | United States | $1.858B | 11.90 |
| Ardent Health Partners (ARDT) | United States | $1.817B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.776B | 38.58 |
| Agilon Health (AGL) | United States | $1.759B | 0.00 |
| PACS (PACS) | United States | $1.468B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.260B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.105B | 9.27 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| CareDx (CDNA) | United States | $0.938B | 14.68 |
| Establishment Labs Holdings (ESTA) | $0.875B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.780B | 6.17 |
| Embecta (EMBC) | United States | $0.709B | 4.86 |
| Nutex Health (NUTX) | United States | $0.608B | 11.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.511B | 13.55 |
| Sonida Senior Living (SNDA) | United States | $0.438B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.405B | 38.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.369B | 0.00 |
| SBC Medicals (SBC) | United States | $0.331B | 0.00 |
| LifeMD (LFMD) | United States | $0.324B | 0.00 |
| DocGo (DCGO) | United States | $0.227B | 9.29 |
| Oncology Institute (TOI) | United States | $0.187B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.185B | 0.00 |
| Beauty Health (SKIN) | United States | $0.124B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.111B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Biodesix (BDSX) | United States | $0.078B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.070B | 0.00 |
| NeueHealth (NEUE) | United States | $0.057B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.021B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 5.95 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |